Inditel CH 40 Tablet is a combination antihypertensive medication containing Telmisartan 40 mg and Chlorthalidone 12.5 mg. Telmisartan is an angiotensin II receptor antagonist that selectively blocks the binding of angiotensin II to the AT1 receptor, thereby inhibiting vasoconstriction and aldosterone secretion, which results in vasodilation and reduction of blood pressure. Chlorthalidone is a thiazide-like diuretic that promotes the excretion of sodium and water by inhibiting sodium reabsorption in the distal convoluted tubules of the kidneys, contributing to decreased plasma volume and peripheral vascular resistance. The synergistic action of these two agents effectively manages hypertension, helping to reduce the risk of cardiovascular events such as stroke and myocardial infarction. Inditel CH 40 is indicated for the treatment of essential hypertension, especially in patients requiring combination therapy to achieve optimal blood pressure control. The combination is well-tolerated but should be used cautiously in patients with renal or hepatic impairment, electrolyte imbalances, or hypersensitivity to sulfonamides. Regular monitoring of blood pressure, renal function, and serum electrolytes is recommended during therapy. Inditel CH 40 Tablet offers a convenient once-daily dosing regimen to enhance patient compliance in hypertension management.